Correlation Between SciVision Biotech and Sinphar Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both SciVision Biotech and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SciVision Biotech and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SciVision Biotech and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on SciVision Biotech and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SciVision Biotech with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of SciVision Biotech and Sinphar Pharmaceutical.
Diversification Opportunities for SciVision Biotech and Sinphar Pharmaceutical
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between SciVision and Sinphar is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding SciVision Biotech and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and SciVision Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SciVision Biotech are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of SciVision Biotech i.e., SciVision Biotech and Sinphar Pharmaceutical go up and down completely randomly.
Pair Corralation between SciVision Biotech and Sinphar Pharmaceutical
Assuming the 90 days trading horizon SciVision Biotech is expected to generate 1.29 times less return on investment than Sinphar Pharmaceutical. In addition to that, SciVision Biotech is 2.04 times more volatile than Sinphar Pharmaceutical Co. It trades about 0.05 of its total potential returns per unit of risk. Sinphar Pharmaceutical Co is currently generating about 0.14 per unit of volatility. If you would invest 3,090 in Sinphar Pharmaceutical Co on November 28, 2024 and sell it today you would earn a total of 55.00 from holding Sinphar Pharmaceutical Co or generate 1.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
SciVision Biotech vs. Sinphar Pharmaceutical Co
Performance |
| Timeline |
| SciVision Biotech |
| Sinphar Pharmaceutical |
SciVision Biotech and Sinphar Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SciVision Biotech and Sinphar Pharmaceutical
The main advantage of trading using opposite SciVision Biotech and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SciVision Biotech position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.| SciVision Biotech vs. Maxigen Biotech | SciVision Biotech vs. Chunghwa Chemical Synthesis | SciVision Biotech vs. Sinphar Pharmaceutical Co | SciVision Biotech vs. ScinoPharm Taiwan |
| Sinphar Pharmaceutical vs. Abnova Taiwan Corp | Sinphar Pharmaceutical vs. YungShin Global Holding | Sinphar Pharmaceutical vs. Phytohealth Corp | Sinphar Pharmaceutical vs. Wellell |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |